WST position history
The shares of West Pharmaceutical Services (WST) that Gates Foundation Trust reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q1: 444,500 shares, $100M, 0.24% of portfolio, New
- 2025 Q2: 444,500 shares, $97M, 0.20% of portfolio
- 2025 Q3: 444,500 shares, $117M, 0.32% of portfolio
- 2025 Q4: 444,500 shares, $122M, 0.35% of portfolio
- 2026 Q1: 444,500 shares, $111M, 0.35% of portfolio
- 2026 Q2: 444,500 shares, $160M, 0.46% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|